Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART for Treatment-Resistant Schizophrenia
NCT04528095Phase 3Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of clozapine, amisulpride in schizophrenia, sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
clozapineamisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04528095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528095.